Delivery Order SPE2DB20D2104-SPE2DB21FU09K
Award Date 9/27/21
Potential Completion Date 9/28/21
Potential Value $102K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,075.74 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg Tablets, a medication used to treat overactive bladder. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical division. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,788.35 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,176.96 firm fixed-price delivery order is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of July 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,536.80 firm fixed price delivery order is for the supply of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The award is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for delivering a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,214.78 firm fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. The contract has an ultimate completion date of August 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,064.61 fixed-price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication used to treat overactive bladder. This contract represents a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,037.25 firm fixed price delivery order is for Myrbetriq ER 25 mg Tablets, a medication used to treat overactive bladder. The award was made on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite...
- This federal contract award, valued at $13,725.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. The contract is a Firm Fixed Price Delivery Order that runs through November 2024. It does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
- This federal contract award, valued at $9,163.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Myrbetriq ER 25 mg tablets, a medication used to treat overactive bladder. This is a delivery order contract with a firm fixed price, and the ultimate completion date is August 9, 2023. The contract does not have a set-aside designation, indicating it was awarded through open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,038.08 firm fixed price delivery order is for the supply of Myrbetriq ER 50 mg tablets, a medication primarily used for the treatment of overactive bladder. The contract has an ultimate completion date of November 10, 2022 and was awarded on November 9, 2022. This delivery order is part of a larger $999,999,999...